World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   841 records for 189 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
RecruitingNCT02404389
Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients
23/01/2015
AuthorisedEUCTR2014-003613-28-AT
study in patients with actinic keratosis (an disease of the skin) with the aim to evaluate the efficacy, the safety and the pharmacokinetics (way the body absorbs, distributes, and gets ride of the drug) of LFX453 after multiple applications to the skin 05/11/2014
RecruitingNCT02251496
COPD: Oral Nutrition Supplements vs. Energy- and Protein Dense in Between Meal Snacks.
25/09/2014
Not recruitingNCT02236455
Effects of Complementary Therapies Delivered Via Mobile Technologies
04/09/2014
AuthorisedEUCTR2013-001811-56-AT
The effect of oral antibiotics on clinical and patient-centered outcomes of implant therapy and simultaneous guided bone regeneration. A randomised controlled clinical trial.
01/09/2014
RecruitingNCT02226120
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2014-001971-30-LVSafety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fraction06/10/2014
AuthorisedEUCTR2014-001971-30-LTSafety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fraction22/10/2014
AuthorisedEUCTR2014-001971-30-PTSafety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fraction18/11/2014
AuthorisedEUCTR2014-001971-30-DKSafety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fraction20/11/2014
AuthorisedEUCTR2014-001971-30-SESafety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fraction10/11/2014
AuthorisedEUCTR2014-001971-30-NLSafety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fraction04/11/2014
AuthorisedEUCTR2014-001971-30-HUSafety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fraction18/11/2014
AuthorisedEUCTR2014-001971-30-BESafety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fraction19/01/2015
AuthorisedEUCTR2014-001971-30-FISafety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fraction29/10/2014
AuthorisedEUCTR2014-001971-30-ITSafety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fraction16/12/2014
AuthorisedEUCTR2014-001971-30-SKSafety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fraction12/11/2014
AuthorisedEUCTR2014-001971-30-EESafety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fraction27/11/2014
25/08/2014
RecruitingNCT02166736
Evaluation of iFR vs FFR in Stable Angina or Acute Coronary Syndrome
07/05/2014
RecruitingNCT02124395
Health-related Quality of Life in Rare Kidney Stone
23/04/2014
RecruitingCTRI/2014/01/004324
Study assessing impact of additional reduction of bad cholesterol on heart related diseases with AMG 145 when used in combination with cholesterol lowering medications
17-01-2014
RecruitingNCT02032823
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Recruitment statusMain IDPublic titleDate of registration
RecruitingJPRN-JapicCTI-142604OlympiA03/07/2014
03/01/2014
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history